As of May 2022 Immutep has a market cap of $0.23 Billion. This makes Immutep the world's 5467th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $0.23 B | -10.33% |
2021 | $0.26 B | 28.54% |
2020 | $0.20 B | 192.13% |
2019 | $0.07 B | 7.29% |
2018 | $0.06 B | 62.83% |
2017 | $0.04 B | -24.9% |
2016 | $0.05 B | -29.42% |
2015 | $0.07 B | 105.96% |
2014 | $0.03 B | -13.17% |
2013 | $0.04 B | -64.92% |
2012 | $0.12 B | -23.44% |
2011 | $0.15 B | |
2009 | $0.05 B |
On May 22nd, 2022 the market cap of Immutep was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Illumina ILMN | $38.25 B | 15,952.13% | ๐บ๐ธ USA |
![]() FibroGen FGEN | $0.80 B | 236.70% | ๐บ๐ธ USA |
![]() HTG Molecular Diagnostics
HTGM | $4.87 M | -97.96% | ๐บ๐ธ USA |